Pictet Asset Management
AVDL

Pictet Asset Management’s Avadel Pharmaceuticals AVDL Stock Holding History

Pictet Asset Management’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-264,974
Closed -$5.71M – 2110
2025
Q4 		$5.71M Buy
264,974
+254,551
+2,442% +$4.94M 0.01% 782
2025
Q3 		$159K Sell
10,423
-1,724
-14% -$22.4K ﹤0.01% 1931
2025
Q2 		$108K Buy
12,147
+1,724
+17% +$15.1K ﹤0.01% 1925
2025
Q1 		$81.6K Hold
10,423
– – ﹤0.01% 1961
2024
Q4 		$110K Hold
10,423
– – ﹤0.01% 1968
2024
Q3 		$137K Buy
+10,423
New +$159K ﹤0.01% 1908

Other funds holding AVDL

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Pictet Asset Management's AVDL Position: Q1 2026 in Review

Pictet Asset Management sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 264,974 shares — an estimated $5.71M sold.

Pictet Asset Management first reported a position in AVDL in Q3 2024 and held it in 6 quarters. The position peaked at $5.71M in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

  • Pictet Asset Management reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Pictet Asset Management sold 264,974 Avadel Pharmaceuticals shares in Q1 2026, an estimated $5.71M.
  • Pictet Asset Management first reported a position in Avadel Pharmaceuticals in Q3 2024 and held it in 6 quarters.
  • Pictet Asset Management's Avadel Pharmaceuticals position peaked at $5.71M in Q4 2025.
  • 2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on Pictet Asset Management's 13F filing for Q1 2026, filed 22 Apr 2026.